Abstract:Objective The purpose of this work is to investigate how the Rho family of GTPases A (RhoA) mediates the pathogenesis of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS). Methods The expression of RhoA in the synovial tissues of RA and Healthy people (Control) was detected using immunohistochemistry methods. The expression of RhoA and hypoxia-inducible factor-1α (HIF-1α) is inhibited by small interfering RNAs (siRNAs). The inhibition effect on RA-FLS migration was further investigated. The protein expression level of HIF-1α, RhoA, focal adhesion kinase (FAK), and myosin light chain (MLC) was also analysed using western blotting (WB). DBA1 mice were immunised with the mixture of bovine type II collagen and Freund's adjuvant to establish collagen induced arthritis (CIA) mouse model. Lip-siRhoA is administered through joint injection every two days. Micro-computed tomography (micro-CT) was used to detect mouse ankle joint destruction and evaluate the bone loss of the periarticular side. Destruction of the ankle articular cartilage was tested by histology. Expressions of P-RhoA, P-FAK and P-MLC in the ankle joint was detected by immunohistochemistry assay. Results The expression level of RhoA in the synovial tissues of RA patients was significantly higher than that in control group. Hypoxia was able to up-regulate the expression of RhoA. Whereas, HIF-1α siRNA (siHIF-1α) could down-regulate the expression of RhoA. Additionally, both of siHIF-1α and RhoA siRNA (siRhoA) delivered by liposome (Lip-siHIF-1α and Lip-siRhoA) were found to suppress FAK and MLC phosphorylation in vitro. In CIA mouse model, Lip-siRhoA was demonstrated to ameliorate the destruction of ankle joint and reduce the severity of ankle joint cartilage damage by micro-CT and histological staining, respectively. Therefore, inhibition of FLS cell migration can protect articular bone from destruction. Furthermore, the expression of P-RhoA, P-FAK and P-MLC was evaluated and found to be down-regulated by Lip-siRhoA in vivo. Conclusion The results demonstrated that under hypoxic environment, HIF-1α dependent RhoA pathway played an important role on cytoskeleton remodelling and RA-FLS migration. Through down-regulating RhoA expression, it could effectively treat RA in vitro and in vivo. The translational potential of this article Our study provides new evidence for the potential clinical application of RhoA as a candidate for the treatment of RA.

Interleukin-35 Inhibits Angiogenesis Through STAT1 Signalling in Rheumatoid Synoviocytes.

IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.

Interleukin-35 Attenuates Collagen-Induced Arthritis Through Suppression of Vascular Endothelial Growth Factor and Its Receptors.

Interleukin-35 (IL-35) Inhibits Proliferation and Promotes Apoptosis of Fibroblast-Like Synoviocytes Isolated from Mice with Collagen-Induced Arthritis

IL-34 Modulates Rheumatoid Synovial Fibroblasts Proliferation and Migration Via ERK/AKT Signalling Pathway.

Interleukin‐35 protein inhibits osteoclastogenesis and attenuates collagen‐induced arthritis in mice

IL-33: a promising therapeutic target for rheumatoid arthritis?

IL-34 affects fibroblast-like synoviocyte proliferation, apoptosis and function by regulating IL-17

Targeting Interleukin-21 in Rheumatoid Arthritis

Interleukin 35 Delays Hindlimb Ischemia-Induced Angiogenesis Through Regulating ROS-Extracellular Matrix but Spares Later Regenerative Angiogenesis

Il-34 Regulates MAPKs, PI3K/Akt, JAK and NF-κB Pathways and Induces the Expression of Inflammatory Factors in RA-FLS.

IL‐35 Ameliorates Collagen‐induced Arthritis by Promoting TNF‐α‐induced Apoptosis of Synovial Fibroblasts and Stimulating M2 Macrophages Polarization

IL-35 (Interleukin-35) Suppresses Endothelial Cell Activation by Inhibiting Mitochondrial Reactive Oxygen Species-Mediated Site-Specific Acetylation of H3K14 (histone 3 Lysine 14).

Interleukin-21 Induces Migration and Invasion of Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis

Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing Mapk-Ap-1 Pathway

Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis.

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

Interleukin-35 Upregulates OPG and Inhibits RANKL in Mice with Collagen-Induced Arthritis and Fibroblast-Like Synoviocytes.

HIF-1α dependent RhoA as a novel therapeutic target to regulate rheumatoid arthritis fibroblast-like synoviocytes migration in vitro and in vivo

Abstract 029: Interleukin-35 Suppresses Endothelial Activation by Inhibiting Mitochondrial Reactive Oxygen Species Mediated Site-specific Acetylation of Histone 3 Lysine 14

Interleukin-21 Induces Proliferation and Proinflammatory Cytokine Profile of Fibroblast-like Synoviocytes of Patients with Rheumatoid Arthritis.